Is it or isn’t it? Celgene said to mull bid for HGS, or not

True or False: Celgene ($CELG) is weighing a bid for Human Genome Sciences ($HGSI). For GlaxoSmithKline ($GSK), the question isn't insignificant. The U.K. drugmaker has its own hostile bid to consider…
Read the full story: News